Search results summary
From Health Canada
Search criteria
- Status: Select all
- Company: MEDEXUS PHARMACEUTICALS INC.
Search results
| Status | DIN | Company | Product | Class | PM See footnote1 | Schedule | # See footnote2 | A.I. name See footnote3 | Strength |
|---|---|---|---|---|---|---|---|---|---|
| Marketed | 02469332 | MEDEXUS PHARMACEUTICALS INC. | CUVPOSA | Human | Yes | Prescription | 1 | GLYCOPYRROLATE | 1 MG / 5 ML |
| Marketed | 02504928 | MEDEXUS PHARMACEUTICALS INC. | GLEOLAN | Human | Yes | Prescription | 1 | AMINOLEVULINIC ACID HYDROCHLORIDE | 1.5 G / VIAL |
| Cancelled Pre Market | 02395185 | MEDEXUS PHARMACEUTICALS INC. | MEDEXUS BULLET | Human | No | OTC | 1 | BISACODYL | 10 MG |
| Cancelled Post Market | 02304767 | MEDEXUS PHARMACEUTICALS INC. | METOJECT | Human | Yes | Prescription | 1 | METHOTREXATE (METHOTREXATE SODIUM) | 20 MG / 2 ML |
| Cancelled Post Market | 02320029 | MEDEXUS PHARMACEUTICALS INC. | METOJECT | Human | Yes | Prescription | 1 | METHOTREXATE (METHOTREXATE SODIUM) | 7.5 MG / 0.75 ML |
| Cancelled Post Market | 02320037 | MEDEXUS PHARMACEUTICALS INC. | METOJECT | Human | Yes | Prescription | 1 | METHOTREXATE (METHOTREXATE SODIUM) | 10 MG / ML |
| Cancelled Post Market | 02320045 | MEDEXUS PHARMACEUTICALS INC. | METOJECT | Human | No | Prescription | 1 | METHOTREXATE (METHOTREXATE SODIUM) | 15 MG / 1.5 ML |
| Cancelled Post Market | 02320053 | MEDEXUS PHARMACEUTICALS INC. | METOJECT | Human | No | Prescription | 1 | METHOTREXATE (METHOTREXATE SODIUM) | 25 MG / 2.5 ML |
| Marketed | 02454750 | MEDEXUS PHARMACEUTICALS INC. | METOJECT SUBCUTANEOUS | Human | Yes | Prescription | 1 | METHOTREXATE (METHOTREXATE SODIUM) | 12.5 MG / 0.25 ML |
| Marketed | 02454769 | MEDEXUS PHARMACEUTICALS INC. | METOJECT SUBCUTANEOUS | Human | Yes | Prescription | 1 | METHOTREXATE (METHOTREXATE SODIUM) | 17.5 MG / 0.35 ML |
| Marketed | 02454777 | MEDEXUS PHARMACEUTICALS INC. | METOJECT SUBCUTANEOUS | Human | Yes | Prescription | 1 | METHOTREXATE (METHOTREXATE SODIUM) | 22.5 MG / 0.45 ML |
| Approved | 02454823 | MEDEXUS PHARMACEUTICALS INC. | METOJECT SUBCUTANEOUS | Human | Yes | Prescription | 1 | METHOTREXATE (METHOTREXATE SODIUM) | 7.5 MG / 0.15 ML |
| Marketed | 02454831 | MEDEXUS PHARMACEUTICALS INC. | METOJECT SUBCUTANEOUS | Human | Yes | Prescription | 1 | METHOTREXATE (METHOTREXATE SODIUM) | 10 MG / 0.2 ML |
| Marketed | 02454858 | MEDEXUS PHARMACEUTICALS INC. | METOJECT SUBCUTANEOUS | Human | Yes | Prescription | 1 | METHOTREXATE (METHOTREXATE SODIUM) | 15 MG / 0.3 ML |
| Marketed | 02454866 | MEDEXUS PHARMACEUTICALS INC. | METOJECT SUBCUTANEOUS | Human | Yes | Prescription | 1 | METHOTREXATE (METHOTREXATE SODIUM) | 20 MG / 0.4 ML |
| Marketed | 02454874 | MEDEXUS PHARMACEUTICALS INC. | METOJECT SUBCUTANEOUS | Human | Yes | Prescription | 1 | METHOTREXATE (METHOTREXATE SODIUM) | 25 MG / 0.5 ML |
| Marketed | 02459655 | MEDEXUS PHARMACEUTICALS INC. | OTIXAL | Human | Yes | Prescription | 2 | CIPROFLOXACIN (CIPROFLOXACIN HYDROCHLORIDE) | 0.3 % / W/V |
| Marketed | 02162431 | MEDEXUS PHARMACEUTICALS INC. | PEDIAPHARM NAPROXEN SUSPENSION | Human | Yes | Prescription | 1 | NAPROXEN | 25 MG / ML |
| Marketed | 02346672 | MEDEXUS PHARMACEUTICALS INC. | RELAXA | Human | Yes | OTC | 1 | POLYETHYLENE GLYCOL 3350 | 100 % |
| Marketed | 02456451 | MEDEXUS PHARMACEUTICALS INC. | RUPALL | Human | Yes | Prescription | 1 | RUPATADINE (RUPATADINE FUMARATE) | 10 MG |
| Marketed | 02456478 | MEDEXUS PHARMACEUTICALS INC. | RUPALL | Human | Yes | Prescription | 1 | RUPATADINE (RUPATADINE FUMARATE) | 1 MG / ML |
| Approved | 02517361 | MEDEXUS PHARMACEUTICALS INC. | TRECONDYV | Human | Yes | Prescription | 1 | TREOSULFAN | 1 G / VIAL |
| Marketed | 02517388 | MEDEXUS PHARMACEUTICALS INC. | TRECONDYV | Human | Yes | Prescription | 1 | TREOSULFAN | 5 G / VIAL |
| Cancelled Post Market | 02470632 | MEDEXUS PHARMACEUTICALS INC. | TRISPAN | Human | Yes | Prescription | 1 | TRIAMCINOLONE HEXACETONIDE | 20 MG / ML |
Application information
Related information
Contact us
Version 4.0.2